HK1010095A1 - Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. - Google Patents

Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.

Info

Publication number
HK1010095A1
HK1010095A1 HK98110925A HK98110925A HK1010095A1 HK 1010095 A1 HK1010095 A1 HK 1010095A1 HK 98110925 A HK98110925 A HK 98110925A HK 98110925 A HK98110925 A HK 98110925A HK 1010095 A1 HK1010095 A1 HK 1010095A1
Authority
HK
Hong Kong
Prior art keywords
byfree
amedicament
dehydroestrone
radicals
manufacture
Prior art date
Application number
HK98110925A
Other languages
English (en)
Inventor
Steven Jay Adelman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1010095A1 publication Critical patent/HK1010095A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98110925A 1995-12-04 1998-09-24 Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. HK1010095A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US793195P 1995-12-04 1995-12-04

Publications (1)

Publication Number Publication Date
HK1010095A1 true HK1010095A1 (en) 1999-06-11

Family

ID=21728885

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110925A HK1010095A1 (en) 1995-12-04 1998-09-24 Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.

Country Status (23)

Country Link
EP (1) EP0778025B1 (sk)
JP (1) JPH09169650A (sk)
KR (1) KR100444002B1 (sk)
CN (1) CN1104900C (sk)
AR (2) AR005866A1 (sk)
AT (1) ATE263565T1 (sk)
AU (1) AU703814B2 (sk)
BR (1) BR9605777A (sk)
CA (1) CA2191835A1 (sk)
CZ (1) CZ289780B6 (sk)
DE (1) DE69632117T2 (sk)
DK (1) DK0778025T3 (sk)
ES (1) ES2215187T3 (sk)
HK (1) HK1010095A1 (sk)
HU (1) HUP9603329A3 (sk)
IL (1) IL119744A (sk)
MX (1) MX9606009A (sk)
NO (1) NO312654B1 (sk)
NZ (1) NZ299858A (sk)
PT (1) PT778025E (sk)
SI (1) SI0778025T1 (sk)
SK (1) SK154296A3 (sk)
ZA (1) ZA969923B (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
ATE518886T1 (de) 2003-06-09 2011-08-15 Redox Reactive Reagents L L C Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen
US7892751B2 (en) 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene

Also Published As

Publication number Publication date
NO312654B1 (no) 2002-06-17
BR9605777A (pt) 1998-08-25
NZ299858A (en) 2001-03-30
CN1158725A (zh) 1997-09-10
KR970032870A (ko) 1997-07-22
IL119744A (en) 2003-01-12
EP0778025B1 (en) 2004-04-07
NO965165D0 (no) 1996-12-03
NO965165L (no) 1997-06-05
CA2191835A1 (en) 1997-06-05
CZ289780B6 (cs) 2002-04-17
ZA969923B (en) 1998-05-26
DK0778025T3 (da) 2004-06-07
HUP9603329A3 (en) 1998-01-28
MX9606009A (es) 1997-08-30
ES2215187T3 (es) 2004-10-01
SK154296A3 (en) 1997-08-06
AR059965A2 (es) 2008-05-14
CZ353296A3 (en) 1997-08-13
SI0778025T1 (en) 2004-08-31
DE69632117T2 (de) 2004-08-26
JPH09169650A (ja) 1997-06-30
KR100444002B1 (ko) 2004-11-03
CN1104900C (zh) 2003-04-09
AU7194496A (en) 1997-06-12
DE69632117D1 (de) 2004-05-13
HUP9603329A2 (en) 1997-08-28
HU9603329D0 (en) 1997-01-28
ATE263565T1 (de) 2004-04-15
PT778025E (pt) 2004-08-31
EP0778025A1 (en) 1997-06-11
AR005866A1 (es) 1999-07-21
IL119744A0 (en) 1997-03-18
AU703814B2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
NL1003813A1 (nl) Inrichting voor de behandeling van luchtwegobstructies.
GR3036315T3 (en) Indolinone compounds for the treatment of disease
ZA949344B (en) Treatment of poultry.
ZA968481B (en) Process for the preparation of 1,1,1,3,3-pentafluoropropane
ZA964298B (en) Use of aryl-substituted cyclobutylalkylamines for the treatment of obesity.
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
EP1126850A4 (en) TREATMENT OF CONDITIONS OF THE RETINA
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3187595A (en) Compounds for the treatment of restenosis
HK1038510A1 (en) Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
IL113057A0 (en) Compositions for the treatment of dandruff
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
GB9516444D0 (en) Process for the production of n,n-dimethyl-n'-phenylureas
EP0774260A4 (en) REMEDY FOR CORNEAL AFFECTIONS
ZA9610761B (en) Medical treatment.
IL118731A (en) Process for the preparation of 2,2-dialkyl-arylidenecycloalkanones
AU6097394A (en) Method for the treatment of respiratory disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081128